Study of Endocrine-Related Conditions and Physiology
The Evaluation and Management of Endocrine-Related Conditions and Physiology
2 other identifiers
observational
1,000
1 country
1
Brief Summary
Background: Endocrine disorders involve changes to glands that produce hormones. Hormones are released by these glands into the blood so they can direct the function of other tissues in the body. Researchers want to study people who may have endocrine disorders. They want to learn more about the conditions that affect endocrine glands. Objective: To study adults with a variety of endocrine disorders for research and physician education. Eligibility: Adults ages 18 and older who have an endocrine or metabolic-related disorder Healthy volunteers 18 and older Design: Participants will be screened with a review of their medical records. Participants will have a physical exam and medical history. The length of the study and the schedule will vary by participant. Tests may include: Blood and urine tests Stool and saliva samples Imaging studies: Participants will lie on a table while a machine takes pictures of the body. They may be injected with a substance to make their organs more visible in the pictures. Tests of endocrine tissue function Consultation with other specialists Sleep study Medical photographs Participants may be treated for their endocrine disorder. This could include: Surgery. If tissue is removed during surgery, it may be studied. Radiation Medicine Participants may have genetic testing. This will be done with a small amount of blood, cells from a cheek swab, or saliva. Sponsoring Institution: National Institute of Digestive, Diabetes and Kidney Disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2019
CompletedFirst Posted
Study publicly available on registry
March 8, 2019
CompletedStudy Start
First participant enrolled
March 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2036
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2036
April 24, 2026
March 31, 2026
16.8 years
March 7, 2019
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnosis/Treatment
determination of diagnosis and/or treatment of an endocrine disorder
variable
Study Arms (2)
Adults with Endocrine Disorder
Adults referred to NIH with possible endocrine conditions
Adults with hyperaldosteronism
Adults referred to NIH or studied at NIH and determined to have hyperaldosteronism
Interventions
one or two side-holes will be created by the interventional radiologist to facilitate adrenal vein sampling
Eligibility Criteria
any adult with a potential endocrine disorder; the types of disorders may vary to ensure that there is an adequate case mix of diagnoses for the training program.
You may qualify if:
- In order to be eligible to participate in this study, an individual must meet all the following criteria:
- Adult men and women age 18 years or older.
- Known or suspected endocrine disorders requiring clinical screening, management and/or treatment and follow-up.
- Stated willingness to comply with all study procedures and availability for the duration of the study
You may not qualify if:
- Unstable participants and participants with severe organ failure, or those with a condition or medical treatment that may affect/limit the endocrine work-up and exhaust Clinical Center, IETP resources will be excluded if appropriate.
- Inability of a subject to adhere to a proposed schedule of visits.
- Inability to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lynnette K Nieman, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2019
First Posted
March 8, 2019
Study Start
March 27, 2019
Primary Completion (Estimated)
January 1, 2036
Study Completion (Estimated)
January 1, 2036
Last Updated
April 24, 2026
Record last verified: 2026-03-31